Clinical Trial Update: Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Bictegravir/FTC/TAF for treatment of primary HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Primary Infection

Drugs mentioned

• Bictegravir/FTC/TAF

Snippet

Sponsor: Anna Cruceta | Conditions: HIV Primary Infection | Phase 2 | Status: UNKNOWN